BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7734405)

  • 1. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.
    Hirosumi J; Nakayama O; Chida N; Inami M; Fagan T; Sawada K; Shigematsu S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):365-73. PubMed ID: 7734405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.
    Hirosumi J; Nakayama O; Fagan T; Sawada K; Chida N; Inami M; Takahashi S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):357-63. PubMed ID: 7734404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs.
    Inami M; Kawamura I; Naoe Y; Tsujimoto S; Mizota T; Manda T; Shimomura K
    Jpn J Pharmacol; 1997 Jun; 74(2):187-94. PubMed ID: 9243327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostates.
    Nakayama O; Hirosumi J; Chida N; Takahashi S; Sawada K; Kojo H; Notsu Y
    Prostate; 1997 Jun; 31(4):241-9. PubMed ID: 9180934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic study of a new nonsteroidal 5 alpha-reductase inhibitor, 4-[3-[3-[Bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-yl]-butyr ic acid, in rats.
    Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):914-20. PubMed ID: 9495849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.
    Homma Y; Kaneko M; Kondo Y; Kawabe K; Kakizoe T
    J Natl Cancer Inst; 1997 Jun; 89(11):803-7. PubMed ID: 9182979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
    Kojo H; Nakayama O; Hirosumi J; Chida N; Notsu Y; Okuhara M
    Mol Pharmacol; 1995 Sep; 48(3):401-6. PubMed ID: 7565619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.
    Maruyama S; Nagasue N; Dhar DK; Yamanoi A; El-Assal ON; Satoh K; Okita K
    Clin Cancer Res; 2001 Jul; 7(7):2096-104. PubMed ID: 11448929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of FK143, a nonsteroidal inhibitor of steroid 5 alpha-reductase, in healthy volunteers.
    Katashima M; Irino T; Shimojo F; Kawamura A; Kageyama H; Higashi N; Miyao Y; Tokuma Y; Hata T; Yamamoto K; Sawada Y; Iga T
    Clin Pharmacol Ther; 1998 Mar; 63(3):354-66. PubMed ID: 9542479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition.
    Henderson NA; Cooke GM; Robaire B
    J Endocrinol; 2006 Sep; 190(3):779-91. PubMed ID: 17003279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).
    van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT
    J Androl; 1997; 18(1):51-61. PubMed ID: 9089068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS; Cai X; Abasolo I; Wang Z
    Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-(1-benzoylindol-3-yl)butyric acids and FK143: novel nonsteroidal inhibitors of steroid 5 alpha-reductase (II).
    Sawada K; Okada S; Golden P; Kayakiri N; Sawada Y; Hashimoto M; Tanaka H
    Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):481-91. PubMed ID: 10319427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
    Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens are not major down-regulators of androgen receptor levels during growth of the immature rat penis .
    Shen R; Lin MC; Sadeghi F; Swerdloff RS; Rajfer J; Gonzalez-Cadavid NF
    J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):301-13. PubMed ID: 8639466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male rats.
    Neubauer BL; Best KL; Blohm TR; Gates C; Goode RL; Hirsch KS; Laughlin ME; Petrow V; Smalstig EB; Stamm NB
    Prostate; 1993; 23(3):181-99. PubMed ID: 8234065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.